| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |